Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

about

Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease

P2860

Q57492024-6001CD08-9898-462C-84FD-5A5FD005597A

P2860

Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

Item

http://www.wikidata.org/entity/Q48592090

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

@en

Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

@nl

type

Item

label

Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

@en

Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

@nl

prefLabel

Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

@en

Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

@nl

P1476

Unmet Needs in the Pathogenesis and Treatment of Vasculitides

@en

P2093

Alessandra Soriano

http://www.w3.org/2001/XMLSchema#string

Carlo Salvarani

http://www.w3.org/2001/XMLSchema#string

Giulia Pazzola

http://www.w3.org/2001/XMLSchema#string

Luigi Boiardi

http://www.w3.org/2001/XMLSchema#string

Nicolò Pipitone

http://www.w3.org/2001/XMLSchema#string

P2860

Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations

Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab.

Etanercept induces remission of polyarteritis nodosa: a case report.

Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare.

Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse.

P2888

s12016-017-8643-2

P304

244-260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12016-017-8643-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Muratore

Stefania Croci

Martina Bonacini

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28895041

http://www.w3.org/2001/XMLSchema#string

Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

about

P2860

P2860

Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698